Iovance Biotherapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Iovance Biotherapeutics Stock Summary

Iovance Biotherapeutics competes with PTC Therapeutics, Krystal Biotech, Sarepta Therapeutics, Madrigal Pharmaceuticals, and CureVac NV. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patients immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Iovance Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.

Iovance Biotherapeutics Key Financial Ratios

Iovance Biotherapeutics Key Balance Sheet Accounts

Iovance Biotherapeutics Key Income Statement Accounts

Iovance Biotherapeutics Key Cash Accounts

Iovance Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Iovance Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Iovance Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Iovance Biotherapeutics competition to find correlations between indicators driving Iovance Biotherapeutics's intrinsic value. More Info.Iovance Biotherapeutics is rated fourth overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Iovance Biotherapeutics' Return On Equity is projected to slightly grow based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Iovance Biotherapeutics' earnings, one of the primary drivers of an investment's value.

Iovance Biotherapeutics' Earnings Breakdown by Geography

Iovance Biotherapeutics Systematic Risk

Today, most investors in Iovance Biotherapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Iovance Biotherapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Iovance Biotherapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Iovance Biotherapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Iovance Biotherapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Iovance Biotherapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Iovance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Iovance Biotherapeutics's daily price indicators and compare them against related drivers.

When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.